{
  "generated": "2026-02-19",
  "total_count": 191,
  "source": "TwTxGNN - https://twtxgnn.yao.care/",
  "drugs": [
    {
      "slug": "acebutolol",
      "name": "Acebutolol",
      "evidence_level": "L4",
      "indication_count": 2,
      "original_indication": "高血壓、狹心症、心律不整",
      "predicted_indication": "惡性腎血管高血壓 (malignant renovascular hypertension)",
      "txgnn_score": "99.10%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/acebutolol/"
    },
    {
      "slug": "acetazolamide",
      "name": "Acetazolamide",
      "evidence_level": "L2",
      "indication_count": 10,
      "original_indication": "青光眼、癲癇、充血性心衰竭水腫",
      "predicted_indication": "心肌病變 (cardiomyopathy)",
      "txgnn_score": "99.83%",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/acetazolamide/"
    },
    {
      "slug": "acitretin",
      "name": "Acitretin",
      "evidence_level": "L3",
      "indication_count": 4,
      "original_indication": "嚴重性牛皮癬、皮膚角化症",
      "predicted_indication": "青春痘 (acne)",
      "txgnn_score": "99.94%",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/acitretin/"
    },
    {
      "slug": "alfacalcidol",
      "name": "Alfacalcidol",
      "evidence_level": "L3",
      "indication_count": 5,
      "original_indication": "骨質疏鬆症、慢性腎不全低血鈣症、副甲狀腺機能低下症、佝僂病、骨軟化症",
      "predicted_indication": "腎小管酸中毒 (renal tubular acidosis)",
      "txgnn_score": "99.27%",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/alfacalcidol/"
    },
    {
      "slug": "alirocumab",
      "name": "Alirocumab",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "預防心血管事件、原發性高血脂症、異合子家族性高膽固醇血症",
      "predicted_indication": "黃色瘤病（Xanthomatosis）、膽固醇分解代謝疾病",
      "txgnn_score": "0.994（黃色瘤病）、0.994（膽固醇代謝疾病）",
      "taiwan_approved": true,
      "decision": "Consider",
      "url": "/drugs/alirocumab/"
    },
    {
      "slug": "allopurinol",
      "name": "Allopurinol",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "痛風症、痛風性關節炎、尿酸結石、高尿酸血症",
      "predicted_indication": "肝性紫質症、苯丙胺酸代謝異常",
      "txgnn_score": "0.999（肝性紫質症）、0.999（苯丙胺酸代謝異常）",
      "taiwan_approved": true,
      "decision": "Explore",
      "url": "/drugs/allopurinol/"
    },
    {
      "slug": "alprostadil",
      "name": "Alprostadil",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "週邊動脈阻塞、勃起功能障礙、先天性心臟缺損新生兒動脈導管維持",
      "predicted_indication": "主動脈畸形、先天性三尖瓣狹窄、心室中隔缺損",
      "txgnn_score": "0.9998（主動脈畸形）、0.999（三尖瓣病變）",
      "taiwan_approved": true,
      "decision": "Validated",
      "url": "/drugs/alprostadil/"
    },
    {
      "slug": "aluminum_chloride",
      "name": "Aluminum Chloride",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "抗多汗、牙齦止血、牙齦收斂",
      "predicted_indication": "脂漏性角化症、脂漏性皮膚炎、痤瘡、皮膚疾病（多汗相關）",
      "txgnn_score": "0.997（脂漏性角化症）、0.996（脂漏性皮膚炎）",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/aluminum_chloride/"
    },
    {
      "slug": "aluminum_hydroxide",
      "name": "Aluminum Hydroxide",
      "evidence_level": "L3",
      "indication_count": 4,
      "original_indication": "胃酸過多、胃炎、胃及十二指腸潰瘍",
      "predicted_indication": "活動性消化性潰瘍 (active peptic ulcer disease)",
      "txgnn_score": "99.64%",
      "taiwan_approved": false,
      "decision": "Proceed with Caution",
      "url": "/drugs/aluminum_hydroxide/"
    },
    {
      "slug": "aluminum_oxide",
      "name": "Aluminum Oxide",
      "evidence_level": "L4",
      "indication_count": 10,
      "original_indication": "緩解胃部不適或灼熱感、或經診斷為胃及十二指腸潰瘍、胃炎、食道炎所伴隨之胃酸過多。",
      "predicted_indication": "類風濕性關節炎 (Rheumatoid Arthritis)",
      "txgnn_score": "99.98%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/aluminum_oxide/"
    },
    {
      "slug": "amcinonide",
      "name": "Amcinonide",
      "evidence_level": "L3",
      "indication_count": 8,
      "original_indication": "異位性皮膚炎、接觸性皮膚炎、濕疹、牛皮癬、神經性皮膚炎",
      "predicted_indication": "皮膚炎 (dermatitis)",
      "txgnn_score": "99.30%",
      "taiwan_approved": false,
      "decision": "Already Approved (原適應症範圍內)",
      "url": "/drugs/amcinonide/"
    },
    {
      "slug": "amorolfine",
      "name": "Amorolfine",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "抗黴菌劑",
      "predicted_indication": "藥物誘發性骨質疏鬆 (Drug-Induced Osteoporosis)",
      "txgnn_score": "99.998%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/amorolfine/"
    },
    {
      "slug": "anastrozole",
      "name": "Anastrozole",
      "evidence_level": "L1",
      "indication_count": 6,
      "original_indication": "停經後婦女晚期乳癌、荷爾蒙接受器陽性早期乳癌輔助治療",
      "predicted_indication": "女性乳腺癌 (female breast carcinoma)",
      "txgnn_score": "99.68%",
      "taiwan_approved": false,
      "decision": "Already Approved (原適應症範圍內)",
      "url": "/drugs/anastrozole/"
    },
    {
      "slug": "aspirin",
      "name": "Aspirin",
      "evidence_level": "L5",
      "indication_count": 0,
      "original_indication": "解熱鎮痛劑",
      "predicted_indication": "無",
      "txgnn_score": "無",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/aspirin/"
    },
    {
      "slug": "atezolizumab",
      "name": "Atezolizumab",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/atezolizumab/"
    },
    {
      "slug": "atracurium_besylate",
      "name": "Atracurium Besylate",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/atracurium_besylate/"
    },
    {
      "slug": "avelumab",
      "name": "Avelumab",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "適用於治療轉移性默克細胞癌 (Merkel Cell Carcinoma)之成人病人。",
      "predicted_indication": "人類皰疹病毒8相關腫瘤 (human herpesvirus 8-related tumor)",
      "txgnn_score": "99.97%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/avelumab/"
    },
    {
      "slug": "belimumab",
      "name": "Belimumab",
      "evidence_level": "L5",
      "indication_count": 6,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/belimumab/"
    },
    {
      "slug": "bempedoic_acid",
      "name": "Bempedoic Acid",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/bempedoic_acid/"
    },
    {
      "slug": "benazepril",
      "name": "Benazepril",
      "evidence_level": "L5",
      "indication_count": 5,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/benazepril/"
    },
    {
      "slug": "benzylpenicillin",
      "name": "Benzylpenicillin",
      "evidence_level": "L5",
      "indication_count": 7,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/benzylpenicillin/"
    },
    {
      "slug": "berberine",
      "name": "Berberine",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "腹瀉、急慢性腸炎、腸內異常醱酵、細菌性痢疾",
      "predicted_indication": "重度子癲前症 (Severe Pre-eclampsia)",
      "txgnn_score": "99.83%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/berberine/"
    },
    {
      "slug": "bevacizumab",
      "name": "Bevacizumab",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/bevacizumab/"
    },
    {
      "slug": "brivaracetam",
      "name": "Brivaracetam",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/brivaracetam/"
    },
    {
      "slug": "brodalumab",
      "name": "Brodalumab",
      "evidence_level": "L4",
      "indication_count": 10,
      "original_indication": "斑塊性乾癬",
      "predicted_indication": "眼病 (Eye Disease)",
      "txgnn_score": "99.82%",
      "taiwan_approved": true,
      "decision": "Research Question",
      "url": "/drugs/brodalumab/"
    },
    {
      "slug": "buprenorphine",
      "name": "Buprenorphine",
      "evidence_level": "L5",
      "indication_count": 6,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/buprenorphine/"
    },
    {
      "slug": "butenafine",
      "name": "Butenafine",
      "evidence_level": "L5",
      "indication_count": 5,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/butenafine/"
    },
    {
      "slug": "caplacizumab",
      "name": "Caplacizumab",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/caplacizumab/"
    },
    {
      "slug": "carbenoxolone",
      "name": "Carbenoxolone",
      "evidence_level": "L5",
      "indication_count": 7,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/carbenoxolone/"
    },
    {
      "slug": "carboplatin",
      "name": "Carboplatin",
      "evidence_level": "L2",
      "indication_count": 10,
      "original_indication": "HER2 陽性早期乳癌、轉移性乳癌、黑色素瘤、非小細胞肺癌、何杰金氏淋巴瘤、頭頸部鱗狀細胞癌、泌尿道上皮癌等",
      "predicted_indication": "女性乳腺癌 (female breast carcinoma)",
      "txgnn_score": "99.86%",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/carboplatin/"
    },
    {
      "slug": "carisoprodol",
      "name": "Carisoprodol",
      "evidence_level": "L5",
      "indication_count": 1,
      "original_indication": "焦慮緊張症、肌炎、椎間神經痛、坐骨神經痛、頸痛、風濕性關節炎、骨關節炎、肌肉僵硬、肌肉痛",
      "predicted_indication": "失眠 (insomnia)",
      "txgnn_score": "99.02%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/carisoprodol/"
    },
    {
      "slug": "caspofungin",
      "name": "Caspofungin",
      "evidence_level": "L5",
      "indication_count": 1,
      "original_indication": "侵入性麴菌病（第二線）、食道念珠菌感染、侵入性念珠菌感染症（含念珠菌血症）、發燒性嗜中性白血球缺乏症之經驗療法",
      "predicted_indication": "胃泌素分泌異常 (gastrin secretion abnormality)",
      "txgnn_score": "99.44%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/caspofungin/"
    },
    {
      "slug": "cefmetazole",
      "name": "Cefmetazole",
      "evidence_level": "L5",
      "indication_count": 9,
      "original_indication": "葡萄球菌、鏈球菌、肺炎雙球菌、腦膜炎球菌及其他具有感受性細菌引起之感染症",
      "predicted_indication": "高澱粉酶血症、多株性高黏滯症候群、先天性無白蛋白血症、血型不相容、淋病性尿道炎、解尿素支原體尿道炎、惡性前血液系統疾病、單株免疫球蛋白血症、血液疾病相關周邊神經病變",
      "txgnn_score": "99.0-99.5%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/cefmetazole/"
    },
    {
      "slug": "cephalexin",
      "name": "Cephalexin",
      "evidence_level": "L5",
      "indication_count": 0,
      "original_indication": "葡萄球菌、鏈球菌、肺炎雙球菌、腦膜炎球菌及其他具有感受性細菌引起之感染症（呼吸道、泌尿道、皮膚軟組織、骨關節等）",
      "predicted_indication": "無",
      "txgnn_score": "無",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/cephalexin/"
    },
    {
      "slug": "cerliponase_alfa",
      "name": "Cerliponase Alfa",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "神經元蠟樣脂褐質儲積症2型 (CLN2)",
      "predicted_indication": "Scheie syndrome",
      "txgnn_score": "99.98%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/cerliponase_alfa/"
    },
    {
      "slug": "chloral_hydrate",
      "name": "Chloral Hydrate",
      "evidence_level": "L5",
      "indication_count": 0,
      "original_indication": "催眠劑、鎮靜劑、兒童檢查（non-painful procedure）前之鎮靜",
      "predicted_indication": "無",
      "txgnn_score": "無",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/chloral_hydrate/"
    },
    {
      "slug": "cisatracurium",
      "name": "Cisatracurium",
      "evidence_level": "L4",
      "indication_count": 10,
      "original_indication": "作為手術全身麻醉劑之輔助劑或加護病房使用，用以鬆弛骨骼肌，幫助氣管插管及與人工呼吸器的協調",
      "predicted_indication": "子癲前症 (Preeclampsia)",
      "txgnn_score": "99.99%",
      "taiwan_approved": true,
      "decision": "Research Question",
      "url": "/drugs/cisatracurium/"
    },
    {
      "slug": "cladribine",
      "name": "Cladribine",
      "evidence_level": "L5",
      "indication_count": 7,
      "original_indication": "",
      "predicted_indication": "橫紋肌肉瘤 (多種亞型)、肝臟肉瘤",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/cladribine/"
    },
    {
      "slug": "clobetasone",
      "name": "Clobetasone",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "外用抗炎性皮質醇",
      "predicted_indication": "原發性皮膚 T 細胞淋巴瘤 (primary cutaneous T-cell lymphoma)",
      "txgnn_score": "99.97%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/clobetasone/"
    },
    {
      "slug": "clomipramine",
      "name": "Clomipramine",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "焦慮症 (anxiety disorder)",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/clomipramine/"
    },
    {
      "slug": "cobicistat",
      "name": "Cobicistat",
      "evidence_level": "L5",
      "indication_count": 3,
      "original_indication": "",
      "predicted_indication": "猴免疫缺乏病毒感染、貓免疫缺乏症候群、神經發育障礙",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/cobicistat/"
    },
    {
      "slug": "cyclizine",
      "name": "Cyclizine",
      "evidence_level": "L5",
      "indication_count": 9,
      "original_indication": "",
      "predicted_indication": "過敏性蕁麻疹、冷蕁麻疹、鼻腔疾病、頭痛疾患",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/cyclizine/"
    },
    {
      "slug": "cytarabine",
      "name": "Cytarabine",
      "evidence_level": "L5",
      "indication_count": 9,
      "original_indication": "",
      "predicted_indication": "小細胞肺癌、原發性肺淋巴瘤",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/cytarabine/"
    },
    {
      "slug": "dehydrocholic_acid",
      "name": "Dehydrocholic Acid",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "利膽劑、膽石症、膽囊炎、膽道炎、肝硬化、黃疸",
      "predicted_indication": "急性尿酸腎病、腎結石、膽道疾病、膽管腫瘤",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/dehydrocholic_acid/"
    },
    {
      "slug": "denosumab",
      "name": "Denosumab",
      "evidence_level": "L5",
      "indication_count": 2,
      "original_indication": "骨質疏鬆症、骨轉移、骨巨細胞瘤、惡性高血鈣症",
      "predicted_indication": "嚴重非增殖性糖尿病視網膜病變、糖尿病視網膜病變",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/denosumab/"
    },
    {
      "slug": "deoxycholic_acid",
      "name": "Deoxycholic Acid",
      "evidence_level": "L5",
      "indication_count": 3,
      "original_indication": "膽固醇性膽結石溶解、原發性膽道肝硬化、頦下脂肪消除",
      "predicted_indication": "家族性血尿-視網膜動脈迂曲-攣縮症候群、腦小血管病變、糖尿病腎病",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/deoxycholic_acid/"
    },
    {
      "slug": "diosmin",
      "name": "Diosmin",
      "evidence_level": "L5",
      "indication_count": 1,
      "original_indication": "慢性靜脈功能不全、靜脈曲張、痔瘡、機能性月經過多",
      "predicted_indication": "閉經 (amenorrhea)",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/diosmin/"
    },
    {
      "slug": "dipyridamole",
      "name": "Dipyridamole",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "慢性狹心症、冠狀動脈不全、血小板凝集降低、心肌灌流造影替代運動試驗",
      "predicted_indication": "變異型心絞痛 (Prinzmetal angina)、中風",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/dipyridamole/"
    },
    {
      "slug": "disopyramide",
      "name": "Disopyramide",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "心室性不整律、心律不整",
      "predicted_indication": "妥瑞症、ADHD、拔毛症、多灶性心房頻脈、新生兒心房撲動",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/disopyramide/"
    },
    {
      "slug": "dl-alpha-tocopherol",
      "name": "Dl-Alpha-Tocopherol",
      "evidence_level": "L4",
      "indication_count": 10,
      "original_indication": "未知",
      "predicted_indication": "未成熟白內障 (immature cataract)",
      "txgnn_score": "99.98%",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/dl-alpha-tocopherol/"
    },
    {
      "slug": "docetaxel",
      "name": "Docetaxel",
      "evidence_level": "L1",
      "indication_count": 10,
      "original_indication": "HER2陽性早期乳癌、轉移性乳癌、轉移性胃癌",
      "predicted_indication": "女性乳腺癌 (female breast carcinoma)",
      "txgnn_score": "99.90%",
      "taiwan_approved": true,
      "decision": "Proceed",
      "url": "/drugs/docetaxel/"
    },
    {
      "slug": "dorzolamide",
      "name": "Dorzolamide",
      "evidence_level": "L3",
      "indication_count": 10,
      "original_indication": "高眼壓症、廣角性青光眼",
      "predicted_indication": "原發性遺傳性青光眼 (primary hereditary glaucoma)",
      "txgnn_score": "99.99%",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/dorzolamide/"
    },
    {
      "slug": "dronedarone",
      "name": "Dronedarone",
      "evidence_level": "L2",
      "indication_count": 10,
      "original_indication": "心房纖維顫動、心房撲動",
      "predicted_indication": "中風疾病 (stroke disorder)",
      "txgnn_score": "99.97%",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/dronedarone/"
    },
    {
      "slug": "dupilumab",
      "name": "Dupilumab",
      "evidence_level": "L3",
      "indication_count": 10,
      "original_indication": "異位性皮膚炎、氣喘、慢性鼻竇炎合併鼻息肉、嗜伊紅性食道炎",
      "predicted_indication": "支氣管炎 (bronchitis)",
      "txgnn_score": "99.92%",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/dupilumab/"
    },
    {
      "slug": "durvalumab",
      "name": "Durvalumab",
      "evidence_level": "L3",
      "indication_count": 10,
      "original_indication": "非小細胞肺癌、小細胞肺癌、膽道癌、肝細胞癌、子宮內膜癌、膀胱癌",
      "predicted_indication": "前列腺尿道泌尿道上皮癌 (prostatic urethra urothelial carcinoma)",
      "txgnn_score": "99.98%",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/durvalumab/"
    },
    {
      "slug": "emedastine",
      "name": "Emedastine",
      "evidence_level": "L5",
      "indication_count": 2,
      "original_indication": "",
      "predicted_indication": "過敏性蕁麻疹、冷蕁麻疹",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/emedastine/"
    },
    {
      "slug": "etanercept",
      "name": "Etanercept",
      "evidence_level": "L5",
      "indication_count": 6,
      "original_indication": "",
      "predicted_indication": "多發性硬化症(primary progressive)、視神經脊髓炎、肌萎縮性脊髓側索硬化症",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/etanercept/"
    },
    {
      "slug": "ethynodiol_diacetate",
      "name": "Ethynodiol Diacetate",
      "evidence_level": "L5",
      "indication_count": 6,
      "original_indication": "",
      "predicted_indication": "痤瘡(acne)、女性不孕症",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/ethynodiol_diacetate/"
    },
    {
      "slug": "famotidine",
      "name": "Famotidine",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "十二指腸胃逆流、十二指腸阻塞、活動性消化性潰瘍",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/famotidine/"
    },
    {
      "slug": "felodipine",
      "name": "Felodipine",
      "evidence_level": "L5",
      "indication_count": 7,
      "original_indication": "",
      "predicted_indication": "肺高壓(肺疾病/缺氧相關)、惡性腎血管性高血壓、惡性高血壓性腎病",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/felodipine/"
    },
    {
      "slug": "fenoprofen",
      "name": "Fenoprofen",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "僵直性脊椎炎、假性軟骨發育不全、WHIM 症候群",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/fenoprofen/"
    },
    {
      "slug": "fenoterol",
      "name": "Fenoterol",
      "evidence_level": "L5",
      "indication_count": 8,
      "original_indication": "",
      "predicted_indication": "多系統萎縮、姿勢性心搏過速症候群、開放性青光眼、雷諾氏病",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/fenoterol/"
    },
    {
      "slug": "ferrous_gluconate",
      "name": "Ferrous Gluconate",
      "evidence_level": "L5",
      "indication_count": 5,
      "original_indication": "",
      "predicted_indication": "Plummer-Vinson 症候群、維生素缺乏症、巨紅血球性貧血",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/ferrous_gluconate/"
    },
    {
      "slug": "flunitrazepam",
      "name": "Flunitrazepam",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "失眠（疾病分類）、偏頭痛、腦幹先兆偏頭痛、焦慮",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/flunitrazepam/"
    },
    {
      "slug": "fosfomycin",
      "name": "Fosfomycin",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "淋病性尿道炎、尿漿菌性尿道炎、子宮炎、會厭炎",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/fosfomycin/"
    },
    {
      "slug": "gefitinib",
      "name": "Gefitinib",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "牙齦纖維瘤、肺纖維瘤、肺錯構瘤、額顳葉失智伴包涵體肌病",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/gefitinib/"
    },
    {
      "slug": "gemcitabine",
      "name": "Gemcitabine",
      "evidence_level": "L2",
      "indication_count": 10,
      "original_indication": "轉移性大腸直腸癌",
      "predicted_indication": "女性乳腺癌 (female breast carcinoma)",
      "txgnn_score": "99.98%",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/gemcitabine/"
    },
    {
      "slug": "griseofulvin",
      "name": "Griseofulvin",
      "evidence_level": "L5",
      "indication_count": 5,
      "original_indication": "",
      "predicted_indication": "蠅蛆症、疥蟲性蠅蛆症、傷口蠅蛆症、爬行性蠅蛆症、包蟲病",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/griseofulvin/"
    },
    {
      "slug": "homatropine_methylbromide",
      "name": "Homatropine Methylbromide",
      "evidence_level": "L5",
      "indication_count": 2,
      "original_indication": "胃酸過多、消化性潰瘍、胃腸道痙攣",
      "predicted_indication": "胃十二指腸炎 (gastroduodenitis)",
      "txgnn_score": "99.39%",
      "taiwan_approved": false,
      "decision": "Hold",
      "url": "/drugs/homatropine_methylbromide/"
    },
    {
      "slug": "human_immunoglobulin_g",
      "name": "Human Immunoglobulin G",
      "evidence_level": "L3",
      "indication_count": 3,
      "original_indication": "原發性免疫不全症、ITP、川崎氏症、GBS",
      "predicted_indication": "糖尿病視網膜病變 (diabetic retinopathy)",
      "txgnn_score": "99.63%",
      "taiwan_approved": false,
      "decision": "Explore",
      "url": "/drugs/human_immunoglobulin_g/"
    },
    {
      "slug": "hydroquinone",
      "name": "Hydroquinone",
      "evidence_level": "L4",
      "indication_count": 4,
      "original_indication": "黑斑、雀斑、色素沉著",
      "predicted_indication": "脂漏性角化症 (seborrheic keratosis)",
      "txgnn_score": "99.73%",
      "taiwan_approved": false,
      "decision": "Hold",
      "url": "/drugs/hydroquinone/"
    },
    {
      "slug": "hydroxyprogesterone_caproate",
      "name": "Hydroxyprogesterone Caproate",
      "evidence_level": "L2",
      "indication_count": 10,
      "original_indication": "習慣性流產、機能性子宮出血、黃體機能不全",
      "predicted_indication": "子宮內膜癌 (endometrial cancer)",
      "txgnn_score": "99.96%",
      "taiwan_approved": false,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/hydroxyprogesterone_caproate/"
    },
    {
      "slug": "hydroxyurea",
      "name": "Hydroxyurea",
      "evidence_level": "L2",
      "indication_count": 10,
      "original_indication": "慢性骨髓性白血病、骨髓纖維化、真性紅血球增多症、卵巢癌、頭頸癌",
      "predicted_indication": "女性乳腺癌 (female breast carcinoma)",
      "txgnn_score": "99.97%",
      "taiwan_approved": false,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/hydroxyurea/"
    },
    {
      "slug": "ibuprofen",
      "name": "Ibuprofen",
      "evidence_level": "L5",
      "indication_count": 7,
      "original_indication": "解熱、鎮痛、關節炎、神經痛",
      "predicted_indication": "肢端肢中發育不良 (acromesomelic dysplasia)",
      "txgnn_score": "99.74%",
      "taiwan_approved": false,
      "decision": "Hold",
      "url": "/drugs/ibuprofen/"
    },
    {
      "slug": "icatibant",
      "name": "Icatibant",
      "evidence_level": "L1",
      "indication_count": 7,
      "original_indication": "遺傳性血管性水腫(HAE)急性發作症狀治療",
      "predicted_indication": "C1 Inhibitor Deficiency",
      "txgnn_score": "99.99%",
      "taiwan_approved": true,
      "decision": "Proceed",
      "url": "/drugs/icatibant/"
    },
    {
      "slug": "inclisiran",
      "name": "Inclisiran",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "原發性高血脂症(含異合子家族性高膽固醇血症)之 LDL-C 降低",
      "predicted_indication": "Potassium Deficiency Disease",
      "txgnn_score": "99.93%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/inclisiran/"
    },
    {
      "slug": "inositol",
      "name": "Inositol",
      "evidence_level": "L3",
      "indication_count": 10,
      "original_indication": "末梢血管循環障礙、營養劑、趨脂劑",
      "predicted_indication": "Familial Hypercholesterolemia",
      "txgnn_score": "99.47%",
      "taiwan_approved": true,
      "decision": "Consider",
      "url": "/drugs/inositol/"
    },
    {
      "slug": "insulin_lispro",
      "name": "Insulin Lispro",
      "evidence_level": "L5",
      "indication_count": 9,
      "original_indication": "糖尿病(成人、青少年及1歲以上兒童)",
      "predicted_indication": "Autoimmune Oophoritis",
      "txgnn_score": "99.78%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/insulin_lispro/"
    },
    {
      "slug": "interferon_beta-1b",
      "name": "Interferon Beta-1B",
      "evidence_level": "L3",
      "indication_count": 2,
      "original_indication": "反覆發作型多發性硬化症、續發型多發性硬化症、臨床孤立症候群",
      "predicted_indication": "Hairy Cell Leukemia",
      "txgnn_score": "99.16%",
      "taiwan_approved": true,
      "decision": "Consider",
      "url": "/drugs/interferon_beta-1b/"
    },
    {
      "slug": "iodixanol",
      "name": "Iodixanol",
      "evidence_level": "L5",
      "indication_count": 3,
      "original_indication": "X光對比劑：心臟血管、腦血管、周邊動脈造影等",
      "predicted_indication": "骨關節炎 (osteoarthritis)",
      "txgnn_score": "99.07%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/iodixanol/"
    },
    {
      "slug": "ipilimumab",
      "name": "Ipilimumab",
      "evidence_level": "L5",
      "indication_count": 2,
      "original_indication": "",
      "predicted_indication": "脈絡膜無虹膜症、非皮膚黑色素瘤",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/ipilimumab/"
    },
    {
      "slug": "ipratropium",
      "name": "Ipratropium",
      "evidence_level": "L1",
      "indication_count": 10,
      "original_indication": "慢性阻塞性支氣管炎、支氣管氣喘、阻塞性呼吸道疾病併發的可逆性支氣管痙攣",
      "predicted_indication": "阻塞性肺疾病 (obstructive lung disease)",
      "txgnn_score": "99.97%",
      "taiwan_approved": true,
      "decision": "Validate",
      "url": "/drugs/ipratropium/"
    },
    {
      "slug": "irbesartan",
      "name": "Irbesartan",
      "evidence_level": "L5",
      "indication_count": 4,
      "original_indication": "本態性高血壓、第二型糖尿病患者的高血壓及糖尿病性腎病變",
      "predicted_indication": "惡性高血壓腎病變、惡性腎血管性高血壓、肺高壓",
      "txgnn_score": "99.31% (惡性高血壓腎病變)",
      "taiwan_approved": true,
      "decision": "Consider",
      "url": "/drugs/irbesartan/"
    },
    {
      "slug": "isoleucine",
      "name": "Isoleucine",
      "evidence_level": "L5",
      "indication_count": 1,
      "original_indication": "",
      "predicted_indication": "胃輕癱 (gastroparesis)",
      "txgnn_score": "0.993",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/isoleucine/"
    },
    {
      "slug": "isosorbide_dinitrate",
      "name": "Isosorbide Dinitrate",
      "evidence_level": "L2",
      "indication_count": 10,
      "original_indication": "預防及治療狹心症發作、冠狀動脈不全",
      "predicted_indication": "肺高壓 (pulmonary hypertension)、脫髮症 (alopecia)",
      "txgnn_score": "99.98% (肺高壓)",
      "taiwan_approved": true,
      "decision": "Explore",
      "url": "/drugs/isosorbide_dinitrate/"
    },
    {
      "slug": "leflunomide",
      "name": "Leflunomide",
      "evidence_level": "L5",
      "indication_count": 2,
      "original_indication": "",
      "predicted_indication": "短指併指症候群 (brachydactyly-syndactyly syndrome)、眼缺損-根莖骨發育不全症候群",
      "txgnn_score": "0.999",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/leflunomide/"
    },
    {
      "slug": "levamisole",
      "name": "Levamisole",
      "evidence_level": "L5",
      "indication_count": 3,
      "original_indication": "抗腫瘍藥，用於氟嘧啶二酮之輔助治療劑",
      "predicted_indication": "藥物誘發性骨質疏鬆症 (drug-induced osteoporosis)",
      "txgnn_score": "99.9993%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/levamisole/"
    },
    {
      "slug": "lidocaine",
      "name": "Lidocaine",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "牙科之表面麻醉、浸潤麻醉、傳達麻醉、局部麻醉",
      "predicted_indication": "點狀上皮角結膜炎 (punctate epithelial keratoconjunctivitis)",
      "txgnn_score": "99.99%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/lidocaine/"
    },
    {
      "slug": "lornoxicam",
      "name": "Lornoxicam",
      "evidence_level": "L3",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "類風濕性關節炎、偏頭痛",
      "txgnn_score": "0.999 (RA)、0.999 (偏頭痛)",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/lornoxicam/"
    },
    {
      "slug": "loteprednol_etabonate",
      "name": "Loteprednol Etabonate",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "濾泡性結膜炎、慢性濾泡性結膜炎、漿液性結膜炎、寄生蟲性結膜炎、偽膜性結膜炎、急性出血性結膜炎、酒糟性結膜炎、外耳炎等",
      "txgnn_score": "0.991-0.997",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/loteprednol_etabonate/"
    },
    {
      "slug": "magnesium_sulfate",
      "name": "Magnesium Sulfate",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "0.99999 (極高)",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/magnesium_sulfate/"
    },
    {
      "slug": "mannitol",
      "name": "Mannitol",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "腎源性抗利尿不當症候群、惡性高熱、家族性週期性麻痺、低血鉀週期性麻痺、腎源性尿崩症、King-Denborough 症候群等",
      "txgnn_score": "0.997-0.999",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/mannitol/"
    },
    {
      "slug": "methionine",
      "name": "Methionine",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "肝機能障礙",
      "predicted_indication": "痤瘡 (Acne)",
      "txgnn_score": "99.9996%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/methionine/"
    },
    {
      "slug": "methocarbamol",
      "name": "Methocarbamol",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "馬尾症候群、腸躁症、全葡萄膜炎、過敏性休克、心室頻脈",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/methocarbamol/"
    },
    {
      "slug": "metoprolol",
      "name": "Metoprolol",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "高血壓、狹心症、心室上心律不整",
      "predicted_indication": "惡性高血壓腎病變、慢性肺心病、心肌梗塞",
      "txgnn_score": "99.91% (惡性高血壓腎病變), 99.40% (慢性肺心病)",
      "taiwan_approved": true,
      "decision": "Explore",
      "url": "/drugs/metoprolol/"
    },
    {
      "slug": "milrinone",
      "name": "Milrinone",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "禿髮症、頭皮單純性毛髮稀疏症、先天性毛髮稀疏症合併粟粒疹、頭痛障礙、充血性心衰竭",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/milrinone/"
    },
    {
      "slug": "minoxidil",
      "name": "Minoxidil",
      "evidence_level": "L4",
      "indication_count": 3,
      "original_indication": "治療女性雄激素性落髮",
      "predicted_indication": "頭皮單純性稀毛症 (hypotrichosis simplex of the scalp)",
      "txgnn_score": "99.99991655349731%",
      "taiwan_approved": true,
      "decision": "Research Question",
      "url": "/drugs/minoxidil/"
    },
    {
      "slug": "moclobemide",
      "name": "Moclobemide",
      "evidence_level": "L5",
      "indication_count": 2,
      "original_indication": "",
      "predicted_indication": "廣場恐懼症、良性陣發性斜頸症",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/moclobemide/"
    },
    {
      "slug": "naftifine",
      "name": "Naftifine",
      "evidence_level": "L1",
      "indication_count": 8,
      "original_indication": "皮膚黴菌病、表皮念珠菌病、甲黴菌病、花斑癬",
      "predicted_indication": "皮膚念珠菌病、花斑癬、Majocchi 肉芽腫",
      "txgnn_score": "99.84% (皮膚念珠菌病), 99.68% (花斑癬)",
      "taiwan_approved": true,
      "decision": "Validate",
      "url": "/drugs/naftifine/"
    },
    {
      "slug": "naphazoline",
      "name": "Naphazoline",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "頭皮毛髮稀疏症、先天性毛髮稀疏症、瀰漫性圓禿、禿髮症、原發性遺傳性青光眼、開角型青光眼",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/naphazoline/"
    },
    {
      "slug": "naproxen",
      "name": "Naproxen",
      "evidence_level": "L5",
      "indication_count": 4,
      "original_indication": "骨關節炎、類風濕性關節炎、急性痛風、原發性經痛、輕中度疼痛",
      "predicted_indication": "短指併指症候群、眼缺損小眼症-根肢發育不良症候群等",
      "txgnn_score": "99.35% (brachydactyly-syndactyly syndrome)",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/naproxen/"
    },
    {
      "slug": "nebivolol",
      "name": "Nebivolol",
      "evidence_level": "L5",
      "indication_count": 5,
      "original_indication": "",
      "predicted_indication": "惡性腎血管性高血壓、惡性高血壓性腎病、肺高壓（低氧相關）、Braddock 症候群",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/nebivolol/"
    },
    {
      "slug": "nefopam",
      "name": "Nefopam",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "鎮痛",
      "predicted_indication": "破傷風性白內障 (Tetanic Cataract)",
      "txgnn_score": "99.98%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/nefopam/"
    },
    {
      "slug": "nepafenac",
      "name": "Nepafenac",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "眼科疾病（廣泛眼科應用）",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/nepafenac/"
    },
    {
      "slug": "nitrofurantoin",
      "name": "Nitrofurantoin",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "尿路感染（膀胱炎、腎盂炎、尿道炎）",
      "predicted_indication": "類風濕性關節炎 (rheumatoid arthritis)",
      "txgnn_score": "99.89%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/nitrofurantoin/"
    },
    {
      "slug": "nystatin",
      "name": "Nystatin",
      "evidence_level": "L4",
      "indication_count": 10,
      "original_indication": "對革蘭氏陽性菌及陰性菌所引起之感染症",
      "predicted_indication": "外陰陰道炎 (Vulvovaginitis)",
      "txgnn_score": "99.92%",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/nystatin/"
    },
    {
      "slug": "omalizumab",
      "name": "Omalizumab",
      "evidence_level": "L2",
      "indication_count": 10,
      "original_indication": "重度過敏性氣喘、慢性鼻竇炎併鼻息肉、慢性自發性蕁麻疹",
      "predicted_indication": "支氣管炎、異位性皮膚炎",
      "txgnn_score": "99.99% (支氣管炎), 99.97% (異位性皮膚炎)",
      "taiwan_approved": true,
      "decision": "Explore",
      "url": "/drugs/omalizumab/"
    },
    {
      "slug": "oteracil",
      "name": "Oteracil",
      "evidence_level": "L2",
      "indication_count": 10,
      "original_indication": "胃癌用藥。",
      "predicted_indication": "大腸腫瘤 (Colonic Neoplasm)",
      "txgnn_score": "99.99%",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/oteracil/"
    },
    {
      "slug": "ouabain",
      "name": "Ouabain",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "心臟衰竭、心房撲動、心房纖維顫動、陣發性上室性心搏過速",
      "predicted_indication": "鐮刀型紅血球貧血 (Sickle cell anemia)、心肌梗塞 (Myocardial infarction)",
      "txgnn_score": "0.995 (鐮刀型紅血球貧血)、0.994 (心肌梗塞)",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/ouabain/"
    },
    {
      "slug": "oxybutynin",
      "name": "Oxybutynin",
      "evidence_level": "L5",
      "indication_count": 3,
      "original_indication": "膀胱過動症、原發性手掌多汗症、膀胱神經控制不適伴隨排尿症狀",
      "predicted_indication": "腸胃道相關疾病",
      "txgnn_score": "高分預測",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/oxybutynin/"
    },
    {
      "slug": "oxytetracycline",
      "name": "Oxytetracycline",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "革蘭氏陽性及陰性菌感染症、螺旋菌感染症、立克次體感染症",
      "predicted_indication": "外耳炎 (Otitis externa)",
      "txgnn_score": "高分預測",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/oxytetracycline/"
    },
    {
      "slug": "paclitaxel",
      "name": "Paclitaxel",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "卵巢癌、乳癌、非小細胞肺癌、胃癌、食道癌、頭頸癌、膀胱癌、子宮頸癌",
      "predicted_indication": "三陰性乳癌、雌激素受體陽性乳癌、荷爾蒙抗性乳癌",
      "txgnn_score": "0.999+",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/paclitaxel/"
    },
    {
      "slug": "pemetrexed",
      "name": "Pemetrexed",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "非小細胞肺癌、惡性胸膜間皮瘤",
      "predicted_indication": "惡性腹膜間皮瘤 (Malignant peritoneal mesothelioma)",
      "txgnn_score": "0.9999+",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/pemetrexed/"
    },
    {
      "slug": "pentosan_polysulfate",
      "name": "Pentosan Polysulfate",
      "evidence_level": "L5",
      "indication_count": 3,
      "original_indication": "間質性膀胱炎引起的膀胱疼痛或不適、栓血症",
      "predicted_indication": "原發性血小板釋放障礙、Glanzmann 血小板無力症、假性類血友病",
      "txgnn_score": "0.996-0.997",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/pentosan_polysulfate/"
    },
    {
      "slug": "pentoxifylline",
      "name": "Pentoxifylline",
      "evidence_level": "L5",
      "indication_count": 0,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/pentoxifylline/"
    },
    {
      "slug": "pimozide",
      "name": "Pimozide",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/pimozide/"
    },
    {
      "slug": "pipemidic_acid",
      "name": "Pipemidic Acid",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/pipemidic_acid/"
    },
    {
      "slug": "pitavastatin",
      "name": "Pitavastatin",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/pitavastatin/"
    },
    {
      "slug": "pitolisant",
      "name": "Pitolisant",
      "evidence_level": "L5",
      "indication_count": 3,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/pitolisant/"
    },
    {
      "slug": "polyethylene_glycol",
      "name": "Polyethylene Glycol",
      "evidence_level": "L5",
      "indication_count": 1,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/polyethylene_glycol/"
    },
    {
      "slug": "polyethylene_glycol_400",
      "name": "Polyethylene Glycol 400",
      "evidence_level": "L5",
      "indication_count": 2,
      "original_indication": "",
      "predicted_indication": "支氣管炎 (bronchitis)、先天性魚鱗癬樣紅皮症",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/polyethylene_glycol_400/"
    },
    {
      "slug": "polymyxin_b",
      "name": "Polymyxin B",
      "evidence_level": "L5",
      "indication_count": 3,
      "original_indication": "",
      "predicted_indication": "支氣管炎 (bronchitis)、喉氣管炎、結膜炎",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/polymyxin_b/"
    },
    {
      "slug": "polysorbate_80",
      "name": "Polysorbate 80",
      "evidence_level": "L5",
      "indication_count": 1,
      "original_indication": "",
      "predicted_indication": "先天性魚鱗癬樣紅皮症 (congenital ichthyosiform erythroderma)",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/polysorbate_80/"
    },
    {
      "slug": "potassium_iodide",
      "name": "Potassium Iodide",
      "evidence_level": "L5",
      "indication_count": 2,
      "original_indication": "",
      "predicted_indication": "鼻腔疾病 (nasal cavity disease)、急性喉咽炎",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/potassium_iodide/"
    },
    {
      "slug": "povidone",
      "name": "Povidone",
      "evidence_level": "L5",
      "indication_count": 1,
      "original_indication": "",
      "predicted_indication": "先天性魚鱗癬樣紅皮症 (congenital ichthyosiform erythroderma)",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/povidone/"
    },
    {
      "slug": "pralatrexate",
      "name": "Pralatrexate",
      "evidence_level": "L4",
      "indication_count": 10,
      "original_indication": "治療復發或頑固型周邊T細胞淋巴瘤(PTCL)。適應症依據為腫瘤反應率，目前沒有資料證實無惡化存活期或整體存活期改善等臨床效益",
      "predicted_indication": "胸膜上皮型間皮瘤 (pleural epithelioid mesothelioma)",
      "txgnn_score": "99.89%",
      "taiwan_approved": true,
      "decision": "Research Question",
      "url": "/drugs/pralatrexate/"
    },
    {
      "slug": "pravastatin",
      "name": "Pravastatin",
      "evidence_level": "L5",
      "indication_count": 9,
      "original_indication": "",
      "predicted_indication": "同合子家族性高膽固醇血症 (hoFH)、HIV感染相關血脂異常",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/pravastatin/"
    },
    {
      "slug": "prednisolone",
      "name": "Prednisolone",
      "evidence_level": "L3",
      "indication_count": 10,
      "original_indication": "濕疹樣皮膚炎、蟲咬傷、尿布疹、皮膚搔癢及過敏性或發炎性皮膚疾患等",
      "predicted_indication": "斑禿 (Alopecia Areata)",
      "txgnn_score": "99.99%",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/prednisolone/"
    },
    {
      "slug": "prednisolone_acetate",
      "name": "Prednisolone Acetate",
      "evidence_level": "L4",
      "indication_count": 10,
      "original_indication": "眼瞼炎、結膜炎、角膜炎、鞏膜炎、虹彩毛樣體炎等過敏性疾患",
      "predicted_indication": "寄生蟲性結膜炎 (Parasitic Conjunctivitis)",
      "txgnn_score": "99.74%",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/prednisolone_acetate/"
    },
    {
      "slug": "prednisone",
      "name": "Prednisone",
      "evidence_level": "L2",
      "indication_count": 10,
      "original_indication": "風濕性關節炎、急性病症（氣喘、休克）、皮膚疾患",
      "predicted_indication": "圓禿症 (Alopecia Areata)",
      "txgnn_score": "99.99%",
      "taiwan_approved": true,
      "decision": "Go",
      "url": "/drugs/prednisone/"
    },
    {
      "slug": "probenecid",
      "name": "Probenecid",
      "evidence_level": "L4",
      "indication_count": 3,
      "original_indication": "痛風、痛風性關節炎、尿酸排泄增進",
      "predicted_indication": "腎性低尿酸血症 (Renal Hypouricemia)",
      "txgnn_score": "99.73%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/probenecid/"
    },
    {
      "slug": "propantheline",
      "name": "Propantheline",
      "evidence_level": "L3",
      "indication_count": 2,
      "original_indication": "胃潰瘍、十二指腸潰瘍、胃炎、胃酸過多",
      "predicted_indication": "胃十二指腸炎 (Gastroduodenitis)",
      "txgnn_score": "99.90%",
      "taiwan_approved": true,
      "decision": "Go",
      "url": "/drugs/propantheline/"
    },
    {
      "slug": "raloxifene",
      "name": "Raloxifene",
      "evidence_level": "L5",
      "indication_count": 4,
      "original_indication": "預防及治療停經後婦女骨質疏鬆症",
      "predicted_indication": "十二指腸潰瘍 (Duodenal Ulcer)",
      "txgnn_score": "99.72%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/raloxifene/"
    },
    {
      "slug": "ramucirumab",
      "name": "Ramucirumab",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "胃癌",
      "predicted_indication": "子宮韌帶腺癌 (Uterine Ligament Adenocarcinoma)",
      "txgnn_score": "99.95%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/ramucirumab/"
    },
    {
      "slug": "regorafenib",
      "name": "Regorafenib",
      "evidence_level": "L2",
      "indication_count": 8,
      "original_indication": "轉移性大腸直腸癌、胃腸道間質腫瘤、肝細胞癌",
      "predicted_indication": "脂肪肉瘤 (Liposarcoma)",
      "txgnn_score": "99.76%",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/regorafenib/"
    },
    {
      "slug": "remdesivir",
      "name": "Remdesivir",
      "evidence_level": "L5",
      "indication_count": 6,
      "original_indication": "新型冠狀病毒疾病（COVID-19）",
      "predicted_indication": "多發性內分泌腫瘤 (Multiple Endocrine Neoplasia)",
      "txgnn_score": "99.50%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/remdesivir/"
    },
    {
      "slug": "ribavirin",
      "name": "Ribavirin",
      "evidence_level": "L3",
      "indication_count": 10,
      "original_indication": "慢性 C 型肝炎（與 peginterferon 或 DAA 併用）",
      "predicted_indication": "慢性 B 型肝炎病毒感染 (Chronic HBV Infection)",
      "txgnn_score": "99.86%",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/ribavirin/"
    },
    {
      "slug": "riluzole",
      "name": "Riluzole",
      "evidence_level": "L4",
      "indication_count": 10,
      "original_indication": "肌萎縮脊髓側索硬化症（ALS）",
      "predicted_indication": "雙側旁矢狀頂枕多小腦回畸形、下運動神經元症候群、Mills 症候群、ALS 易感性",
      "txgnn_score": "99.94%-99.98%",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/riluzole/"
    },
    {
      "slug": "ritonavir",
      "name": "Ritonavir",
      "evidence_level": "L4",
      "indication_count": 3,
      "original_indication": "人類免疫缺乏病毒（HIV）感染",
      "predicted_indication": "猿免疫缺乏病毒感染 (SIV Infection)、貓愛滋病",
      "txgnn_score": "99.92%",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/ritonavir/"
    },
    {
      "slug": "ropinirole",
      "name": "Ropinirole",
      "evidence_level": "L4",
      "indication_count": 10,
      "original_indication": "治療自發性帕金森氏症、原發性腳部躁動症",
      "predicted_indication": "思覺失調症 (schizophrenia)",
      "txgnn_score": "99.90%",
      "taiwan_approved": true,
      "decision": "Worth Exploring",
      "url": "/drugs/ropinirole/"
    },
    {
      "slug": "rotigotine",
      "name": "Rotigotine",
      "evidence_level": "L4",
      "indication_count": 10,
      "original_indication": "原發性帕金森氏症",
      "predicted_indication": "思覺失調症 (schizophrenia)",
      "txgnn_score": "99.996%",
      "taiwan_approved": true,
      "decision": "Worth Exploring",
      "url": "/drugs/rotigotine/"
    },
    {
      "slug": "sacituzumab_govitecan",
      "name": "Sacituzumab Govitecan",
      "evidence_level": "L5",
      "indication_count": 4,
      "original_indication": "晚期三陰性乳癌、HR+/HER2- 乳癌",
      "predicted_indication": "藥物誘發性骨質疏鬆症 (drug-induced osteoporosis)",
      "txgnn_score": "99.78%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/sacituzumab_govitecan/"
    },
    {
      "slug": "salicylamide",
      "name": "Salicylamide",
      "evidence_level": "L4",
      "indication_count": 10,
      "original_indication": "解熱鎮痛、風濕關節痛、神經痛、肌肉痛",
      "predicted_indication": "普通感冒 (common cold)、咽炎 (pharyngitis)",
      "txgnn_score": "99.93% (咽炎)、99.26% (普通感冒)",
      "taiwan_approved": true,
      "decision": "Worth Exploring",
      "url": "/drugs/salicylamide/"
    },
    {
      "slug": "salicylic_acid",
      "name": "Salicylic Acid",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "抗皮膚角化劑、殺菌、角質軟化、解熱鎮痛",
      "predicted_indication": "Papillary Conjunctivitis",
      "txgnn_score": "99.88%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/salicylic_acid/"
    },
    {
      "slug": "scopolamine",
      "name": "Scopolamine",
      "evidence_level": "L5",
      "indication_count": 6,
      "original_indication": "胃腸痙攣、膽管痙攣、尿路痙攣、女性生殖器痙攣",
      "predicted_indication": "Cauda Equina Syndrome（馬尾症候群）",
      "txgnn_score": "99.99%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/scopolamine/"
    },
    {
      "slug": "silicon_dioxide",
      "name": "Silicon Dioxide",
      "evidence_level": "L4",
      "indication_count": 4,
      "original_indication": "賦形劑、制酸劑、胃酸過多、氣體吸著劑",
      "predicted_indication": "Active Peptic Ulcer Disease（活動性消化性潰瘍）",
      "txgnn_score": "99.93%",
      "taiwan_approved": true,
      "decision": "可進一步探索",
      "url": "/drugs/silicon_dioxide/"
    },
    {
      "slug": "simoctocog_alfa",
      "name": "Simoctocog Alfa",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "治療與預防 A 型血友病（先天性第八凝血因子缺乏）病人的出血",
      "predicted_indication": "Pseudo-von Willebrand Disease（類乙型威勒布蘭氏病）",
      "txgnn_score": "99.997%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/simoctocog_alfa/"
    },
    {
      "slug": "sodium_carbonate",
      "name": "Sodium Carbonate",
      "evidence_level": "L5",
      "indication_count": 6,
      "original_indication": "制酸劑、無菌製劑輔助劑（鹼化藥）、抗生素輔助劑",
      "predicted_indication": "過敏反應（anaphylaxis）、乾眼症（dry eye syndrome）",
      "txgnn_score": "0.997（anaphylaxis）",
      "taiwan_approved": false,
      "decision": "Watch",
      "url": "/drugs/sodium_carbonate/"
    },
    {
      "slug": "sodium_citrate",
      "name": "Sodium Citrate",
      "evidence_level": "L5",
      "indication_count": 9,
      "original_indication": "抗凝血劑、袪痰劑、促進利尿、制酸",
      "predicted_indication": "胃部疾病（stomach disease）、胃十二指腸炎（gastroduodenitis）",
      "txgnn_score": "0.999（stomach disease）",
      "taiwan_approved": false,
      "decision": "Watch",
      "url": "/drugs/sodium_citrate/"
    },
    {
      "slug": "sulfamerazine",
      "name": "Sulfamerazine",
      "evidence_level": "L5",
      "indication_count": 4,
      "original_indication": "磺胺劑、革蘭氏陽性及陰性菌感染症",
      "predicted_indication": "結膜炎（conjunctivitis）、痛風（gout）",
      "txgnn_score": "0.990（conjunctivitis）",
      "taiwan_approved": false,
      "decision": "Hold",
      "url": "/drugs/sulfamerazine/"
    },
    {
      "slug": "sulfamethazine",
      "name": "Sulfamethazine",
      "evidence_level": "L5",
      "indication_count": 6,
      "original_indication": "磺胺劑、革蘭氏陽性及陰性菌感染症",
      "predicted_indication": "糖尿病腎病變（diabetic nephropathy）、結膜炎（conjunctivitis）、支氣管炎（bronchitis）",
      "txgnn_score": "0.998（diabetic nephropathy）",
      "taiwan_approved": false,
      "decision": "Hold",
      "url": "/drugs/sulfamethazine/"
    },
    {
      "slug": "tazarotene",
      "name": "Tazarotene",
      "evidence_level": "L5",
      "indication_count": 3,
      "original_indication": "乾癬及尋常性痤瘡",
      "predicted_indication": "脂漏性皮膚炎 (Seborrheic Dermatitis)",
      "txgnn_score": "99.79%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/tazarotene/"
    },
    {
      "slug": "temozolomide",
      "name": "Temozolomide",
      "evidence_level": "L1",
      "indication_count": 2,
      "original_indication": "神經膠母細胞瘤（與放射治療同步及輔助治療）",
      "predicted_indication": "成人星狀細胞瘤 (Adult Astrocytic Tumour)",
      "txgnn_score": "99.36%",
      "taiwan_approved": true,
      "decision": "Go",
      "url": "/drugs/temozolomide/"
    },
    {
      "slug": "tenofovir_alafenamide",
      "name": "Tenofovir Alafenamide",
      "evidence_level": "L5",
      "indication_count": 3,
      "original_indication": "",
      "predicted_indication": "SIV 感染、貓愛滋病、神經發育障礙",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/tenofovir_alafenamide/"
    },
    {
      "slug": "terbutaline",
      "name": "Terbutaline",
      "evidence_level": "L5",
      "indication_count": 3,
      "original_indication": "",
      "predicted_indication": "阻塞性肺病（COPD）",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/terbutaline/"
    },
    {
      "slug": "teriparatide",
      "name": "Teriparatide",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "妊娠相關骨質疏鬆症（PLO）、十二指腸潰瘍、食道疾病",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/teriparatide/"
    },
    {
      "slug": "tetrabenazine",
      "name": "Tetrabenazine",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "多囊性腎病第 3 型、腎-肝-胰發育不全、乳乙伯症候群",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/tetrabenazine/"
    },
    {
      "slug": "tetryzoline",
      "name": "Tetryzoline",
      "evidence_level": "L4",
      "indication_count": 2,
      "original_indication": "眼睛刺激、結膜炎、結膜充血",
      "predicted_indication": "鼻腔疾病 (Nasal Cavity Disease)",
      "txgnn_score": "99.98%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/tetryzoline/"
    },
    {
      "slug": "theophylline",
      "name": "Theophylline",
      "evidence_level": "L5",
      "indication_count": 7,
      "original_indication": "",
      "predicted_indication": "鼻腔疾病（嗅覺障礙）、阻塞性肺病、氣管疾病、血栓性疾病",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/theophylline/"
    },
    {
      "slug": "thiamine",
      "name": "Thiamine",
      "evidence_level": "L5",
      "indication_count": 4,
      "original_indication": "",
      "predicted_indication": "甲狀腺亢進、甲狀腺素受體 beta 突變、開角型青光眼",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/thiamine/"
    },
    {
      "slug": "threonine",
      "name": "Threonine",
      "evidence_level": "L5",
      "indication_count": 1,
      "original_indication": "營養補充劑、氨基酸補給劑",
      "predicted_indication": "Gastroparesis（胃輕癱）",
      "txgnn_score": "99.32%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/threonine/"
    },
    {
      "slug": "tiaprofenic_acid",
      "name": "Tiaprofenic Acid",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "消炎鎮痛",
      "predicted_indication": "Brachydactyly-Syndactyly Syndrome（首位）",
      "txgnn_score": "99.99%（最高分）",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/tiaprofenic_acid/"
    },
    {
      "slug": "timepidium",
      "name": "Timepidium",
      "evidence_level": "L5",
      "indication_count": 1,
      "original_indication": "胃腸道平滑肌痙攣性疼痛（胃炎、消化性潰瘍、腸炎、膽道疾患、尿路結石、胰臟炎）",
      "predicted_indication": "失眠症 (insomnia)",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/timepidium/"
    },
    {
      "slug": "tinidazole",
      "name": "Tinidazole",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "陰道滴蟲症、阿米巴症、梨形鞭毛蟲症",
      "predicted_indication": "停經後萎縮性陰道炎、外陰潰瘍、外陰腫瘤、乳房纖維囊腫、AIDS 等",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/tinidazole/"
    },
    {
      "slug": "tioconazole",
      "name": "Tioconazole",
      "evidence_level": "L5",
      "indication_count": 3,
      "original_indication": "感受性黴菌引起之局部感染症",
      "predicted_indication": "外陰陰道炎 (vulvovaginitis)",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/tioconazole/"
    },
    {
      "slug": "titanium_dioxide",
      "name": "Titanium Dioxide",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "外用抗刺激劑",
      "predicted_indication": "藥物誘發的骨質疏鬆",
      "txgnn_score": "99.99%",
      "taiwan_approved": false,
      "decision": "Hold",
      "url": "/drugs/titanium_dioxide/"
    },
    {
      "slug": "tizanidine",
      "name": "Tizanidine",
      "evidence_level": "L5",
      "indication_count": 6,
      "original_indication": "神經疾患所引起之痙攣症狀、疼痛性肌肉痙攣",
      "predicted_indication": "偏頭痛 (migraine disorder)、伴腦幹預兆偏頭痛、妥瑞氏症等",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/tizanidine/"
    },
    {
      "slug": "tofacitinib",
      "name": "Tofacitinib",
      "evidence_level": "L5",
      "indication_count": 0,
      "original_indication": "類風濕性關節炎、乾癬性關節炎、僵直性脊椎炎、潰瘍性結腸炎、多關節型兒童特發性關節炎",
      "predicted_indication": "**無**（TxGNN 未預測出符合條件的新適應症）",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/tofacitinib/"
    },
    {
      "slug": "tolmetin",
      "name": "Tolmetin",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "類風濕性關節炎、骨關節炎、僵直性脊椎炎、急性痛風",
      "predicted_indication": "肢端中段發育不全、短軀幹發育不良、肌硬化症、假性軟骨發育不全等罕病",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/tolmetin/"
    },
    {
      "slug": "trabectedin",
      "name": "Trabectedin",
      "evidence_level": "L5",
      "indication_count": 1,
      "original_indication": "無法切除或轉移性脂肪肉瘤/平滑肌肉瘤",
      "predicted_indication": "女性乳腺癌 (female breast carcinoma)",
      "txgnn_score": "99.73%",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/trabectedin/"
    },
    {
      "slug": "tranexamic_acid",
      "name": "Tranexamic Acid",
      "evidence_level": "L5",
      "indication_count": 1,
      "original_indication": "全身及局部出血或出血性疾病",
      "predicted_indication": "閉經 (amenorrhea)",
      "txgnn_score": "99.19%",
      "taiwan_approved": true,
      "decision": "Needs Further Investigation",
      "url": "/drugs/tranexamic_acid/"
    },
    {
      "slug": "trastuzumab_deruxtecan",
      "name": "Trastuzumab Deruxtecan",
      "evidence_level": "L5",
      "indication_count": 1,
      "original_indication": "HER2 陽性乳癌、非小細胞肺癌、胃癌、實體腫瘤",
      "predicted_indication": "藥物誘發性骨質疏鬆 (drug-induced osteoporosis)",
      "txgnn_score": "99.31%",
      "taiwan_approved": true,
      "decision": "Not Recommended",
      "url": "/drugs/trastuzumab_deruxtecan/"
    },
    {
      "slug": "travoprost",
      "name": "Travoprost",
      "evidence_level": "L5",
      "indication_count": 3,
      "original_indication": "降低隅角開放性青光眼、慢性隅角閉鎖性青光眼患者的眼壓",
      "predicted_indication": "內臟鈣化皮炎 (Visceral Calciphylaxis)",
      "txgnn_score": "99.9998%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/travoprost/"
    },
    {
      "slug": "treprostinil",
      "name": "Treprostinil",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "特發性或遺傳性肺動脈高壓 (WHO functional class III/IV)",
      "predicted_indication": "肺動脈高壓相關疾病（先天性心臟病、HIV 感染、結締組織疾病等）",
      "txgnn_score": "",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/treprostinil/"
    },
    {
      "slug": "trifluoperazine",
      "name": "Trifluoperazine",
      "evidence_level": "L5",
      "indication_count": 1,
      "original_indication": "精神病狀態、噁心嘔吐、攻擊性與破壞性行為障礙",
      "predicted_indication": "躁鬱症躁症期 (manic bipolar affective disorder)",
      "txgnn_score": "99.51%",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/trifluoperazine/"
    },
    {
      "slug": "trihexyphenidyl",
      "name": "Trihexyphenidyl",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/trihexyphenidyl/"
    },
    {
      "slug": "tyrosine",
      "name": "Tyrosine",
      "evidence_level": "L5",
      "indication_count": 10,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/tyrosine/"
    },
    {
      "slug": "urea",
      "name": "Urea",
      "evidence_level": "L5",
      "indication_count": 0,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/urea/"
    },
    {
      "slug": "verteporfin",
      "name": "Verteporfin",
      "evidence_level": "L5",
      "indication_count": 1,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": false,
      "decision": "",
      "url": "/drugs/verteporfin/"
    },
    {
      "slug": "vigabatrin",
      "name": "Vigabatrin",
      "evidence_level": "L5",
      "indication_count": 0,
      "original_indication": "抗癲癇之輔助療法",
      "predicted_indication": "無",
      "txgnn_score": "N/A",
      "taiwan_approved": true,
      "decision": "無老藥新用候選",
      "url": "/drugs/vigabatrin/"
    },
    {
      "slug": "vinorelbine",
      "name": "Vinorelbine",
      "evidence_level": "L3",
      "indication_count": 10,
      "original_indication": "非小細胞肺癌、轉移性乳癌",
      "predicted_indication": "Ewing 肉瘤 (Ewing sarcoma)",
      "txgnn_score": "99.999%",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/vinorelbine/"
    },
    {
      "slug": "vismodegib",
      "name": "Vismodegib",
      "evidence_level": "L4",
      "indication_count": 10,
      "original_indication": "治療轉移性基底細胞癌，或不適合接受手術或放射線治療之局部晚期基底細胞癌成人病患。",
      "predicted_indication": "著色性乾皮症 (Xeroderma Pigmentosum)",
      "txgnn_score": "99.91%",
      "taiwan_approved": true,
      "decision": "Research Question",
      "url": "/drugs/vismodegib/"
    },
    {
      "slug": "vitamin_e",
      "name": "Vitamin E",
      "evidence_level": "L3",
      "indication_count": 10,
      "original_indication": "習慣性早流產、末梢血行障礙、維生素 E 缺乏症",
      "predicted_indication": "先天性膽紅素代謝異常 (inborn disorder of bilirubin metabolism)",
      "txgnn_score": "99.99%",
      "taiwan_approved": true,
      "decision": "Proceed with Caution",
      "url": "/drugs/vitamin_e/"
    },
    {
      "slug": "vonoprazan",
      "name": "Vonoprazan",
      "evidence_level": "L2",
      "indication_count": 10,
      "original_indication": "糜爛性食道炎、胃潰瘍、十二指腸潰瘍、幽門螺旋桿菌根除輔助",
      "predicted_indication": "活動性消化性潰瘍 (active peptic ulcer disease)",
      "txgnn_score": "99.97%",
      "taiwan_approved": true,
      "decision": "Strong Proceed",
      "url": "/drugs/vonoprazan/"
    },
    {
      "slug": "voriconazole",
      "name": "Voriconazole",
      "evidence_level": "L5",
      "indication_count": 0,
      "original_indication": "侵犯性麴菌症、侵犯性念珠菌感染、足分枝菌/鐮刀菌感染、預防侵入性黴菌感染",
      "predicted_indication": "無",
      "txgnn_score": "N/A",
      "taiwan_approved": true,
      "decision": "無老藥新用候選",
      "url": "/drugs/voriconazole/"
    },
    {
      "slug": "warfarin",
      "name": "Warfarin",
      "evidence_level": "L5",
      "indication_count": 3,
      "original_indication": "抗凝血劑",
      "predicted_indication": "Heparin Cofactor 2 Deficiency",
      "txgnn_score": "99.87%",
      "taiwan_approved": true,
      "decision": "Hold",
      "url": "/drugs/warfarin/"
    },
    {
      "slug": "warfarin_af",
      "name": "Warfarin Af",
      "evidence_level": "L5",
      "indication_count": 0,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": true,
      "decision": "標準治療",
      "url": "/drugs/warfarin_af/"
    },
    {
      "slug": "warfarin_atrial_fibrillation",
      "name": "Warfarin Atrial Fibrillation",
      "evidence_level": "L5",
      "indication_count": 0,
      "original_indication": "",
      "predicted_indication": "",
      "txgnn_score": "",
      "taiwan_approved": true,
      "decision": "標準治療（非老藥新用候選）",
      "url": "/drugs/warfarin_atrial_fibrillation/"
    },
    {
      "slug": "xylitol",
      "name": "Xylitol",
      "evidence_level": "L5",
      "indication_count": 1,
      "original_indication": "糖尿病代謝異常、醣類補充",
      "predicted_indication": "腦膜炎球菌感染 (meningococcal infection)",
      "txgnn_score": "99.66%",
      "taiwan_approved": false,
      "decision": "Wait for More Evidence",
      "url": "/drugs/xylitol/"
    },
    {
      "slug": "xylometazoline",
      "name": "Xylometazoline",
      "evidence_level": "L5",
      "indication_count": 2,
      "original_indication": "感冒、鼻塞、過敏性鼻炎",
      "predicted_indication": "鼻腔疾病、急性咽喉炎",
      "txgnn_score": "99.91% (鼻腔疾病)、99.89% (急性咽喉炎)",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/xylometazoline/"
    },
    {
      "slug": "zanubrutinib",
      "name": "Zanubrutinib",
      "evidence_level": "L5",
      "indication_count": 6,
      "original_indication": "被套細胞淋巴瘤 (MCL)、華氏巨球蛋白血症 (WM)、CLL/SLL、邊緣區淋巴瘤、濾泡性淋巴瘤",
      "predicted_indication": "骨髓性白血病 (myeloid leukemia)",
      "txgnn_score": "99.65%",
      "taiwan_approved": true,
      "decision": "Proceed with Guardrails",
      "url": "/drugs/zanubrutinib/"
    }
  ]
}